Hangzhou ApexTide Biomedical Technology Co., Ltd.
FDA inspection history in Hangzhou, China, 2024
- 1
- Form 483
Every document, by year
- Form 483
2024: one Form 483.
The story so far
Built from the dates and citations on the documents themselves.
- 2024One Form 483, at Hangzhou, China.
Cited most
Across all Hangzhou ApexTide Biomedical Technology Co. observations on file
- 21 CFR 211.113Control of microbiological contamination2
- 21 CFR 211.100Written procedures; deviations1
- 21 CFR 211.160General requirements1
- 21 CFR 211.166Stability testing1
- 21 CFR 211.192Production record review1
The complete Hangzhou ApexTide Biomedical Technology Co. file.
All 1 documents as original PDFs. For supplier audits, diligence and inspection prep.
Sites
Hangzhou, China
One Form 483 · 2024 · 10 observations
Latest: Form 483, Nov 1, 2024 →
Documents
1 on file, newest first| Date | Document | Location | Observations | Price |
|---|---|---|---|---|
| 2024-11-01 | 483 Form 483 | Hangzhou, China | 10 | $99 |
Investigators on these documents
FEI number 3027905876 · most recent document Nov 1, 2024
About Hangzhou ApexTide Biomedical Technology Co., Ltd.
How many FDA Form 483s has Hangzhou ApexTide Biomedical Technology Co., Ltd. received?
FDA Intel has 1 Form 483 on file for Hangzhou ApexTide Biomedical Technology Co., Ltd.; the most recent is dated Nov 1, 2024.
When was Hangzhou ApexTide Biomedical Technology Co., Ltd. last inspected by FDA?
The most recent FDA inspection document on file for Hangzhou ApexTide Biomedical Technology Co., Ltd. is a Form 483 dated Nov 1, 2024, for the site in Hangzhou, China.
What did FDA cite at Hangzhou ApexTide Biomedical Technology Co., Ltd.?
The regulations cited most in the observations on file for Hangzhou ApexTide Biomedical Technology Co., Ltd. are 21 CFR 211.113 (Control of microbiological contamination), 2 times; 21 CFR 211.100 (Written procedures; deviations), 1 time; 21 CFR 211.160 (General requirements), 1 time.